Conjugated estrogens/methyltestosterone Interactions
There are 285 drugs known to interact with conjugated estrogens/methyltestosterone, along with 27 disease interactions, and 4 alcohol/food interactions. Of the total drug interactions, 39 are major, 227 are moderate, and 19 are minor.
- View all 285 medications that may interact with conjugated estrogens/methyltestosterone
- View conjugated estrogens/methyltestosterone alcohol/food interactions (4)
- View conjugated estrogens/methyltestosterone disease interactions (27)
Most frequently checked interactions
View interaction reports for conjugated estrogens / methyltestosterone and the medicines listed below.
- Abilify (aripiprazole)
- Adderall (amphetamine / dextroamphetamine)
- Advair Diskus (fluticasone / salmeterol)
- Allegra (fexofenadine)
- Amitiza (lubiprostone)
- Colace (docusate)
- Cymbalta (duloxetine)
- DHEA (dehydroepiandrosterone)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- Humira (adalimumab)
- Klonopin (clonazepam)
- Lamictal (lamotrigine)
- Lexapro (escitalopram)
- Lipitor (atorvastatin)
- Lyrica (pregabalin)
- Nexium (esomeprazole)
- Norco (acetaminophen / hydrocodone)
- Omega-3 (omega-3 polyunsaturated fatty acids)
- Premarin Vaginal (conjugated estrogens topical)
- Prilosec (omeprazole)
- Probiotic Formula (bifidobacterium infantis / lactobacillus acidophilus)
- Protonix (pantoprazole)
- Requip (ropinirole)
- Singulair (montelukast)
- Synthroid (levothyroxine)
- Topamax (topiramate)
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
- Wellbutrin (bupropion)
- Zyrtec (cetirizine)
Conjugated estrogens/methyltestosterone alcohol/food interactions
There are 4 alcohol/food interactions with conjugated estrogens / methyltestosterone.
Conjugated estrogens/methyltestosterone disease interactions
There are 27 disease interactions with conjugated estrogens / methyltestosterone which include:
- carcinoma (male)
- fluid retention
- hypercalcemia in breast cancer
- hyperlipoproteinemia
- liver disease
- polycythemia
- suppression of clotting factors
- abnormal vaginal bleeding
- carcinomas (estrogenic)
- hypercalcemia in breast cancer
- hypertension
- thromboembolism/cardiovascular
- hepatic neoplasms
- diabetes
- hypercalcemia
- angioedema
- gallbladder disease
- hypercalcemia
- hyperlipidemia
- liver disease
- melasma
- depression
- fluid retention
- glucose intolerance
- retinal thrombosis
- thyroid function tests
- thyroid function tests
Report options
More about conjugated estrogens / methyltestosterone
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
